Aopline Health Industry Technology (Guangzhou) Co., Ltd. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection OAI · Nov 8, 2024
  • No warning letters matched by name
Inspections 1 1 OAI
Recalls 0 0 Class I
Warning letters 0 None on file
510(k) clearances 0 None on file

Aopline Health Industry Technology (Guangzhou) Co., Ltd. has 0 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Aopline Health Industry Technology (Guangzhou) Co., Ltd." is on file.

What these totals cover: FDA records filed under the name "Aopline Health Industry Technology (Guangzhou) Co., Ltd." and its spelling variant "Aopline Health Industry Technology (Guangzhou) Co".

Latest inspection
Nov 8, 2024 · OAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 8, 2026File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections1Nov 15, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Reviewing Aopline Health Industry Technology (Guangzhou) Co., Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Aopline Health Industry Technology (Guangzhou) Co., Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

1 inspection on Nov 8, 2024.

DateSiteProductClassificationFEI
Nov 8, 2024Guangzhou, ChinaDrugsOfficial Action Indicated (OAI)3022553689
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3022553689Guangzhou, China1Nov 8, 2024

Aopline Health Industry Technology (Guangzhou) Co., Ltd. and the FDA: common questions

Has Aopline Health Industry Technology (Guangzhou) Co., Ltd. received an FDA warning letter?

No FDA warning letter addressed to the name "Aopline Health Industry Technology (Guangzhou) Co., Ltd." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Aopline Health Industry Technology (Guangzhou) Co., Ltd. received an FDA Form 483?

FDA has not published a Form 483 for "Aopline Health Industry Technology (Guangzhou) Co., Ltd." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Aopline Health Industry Technology (Guangzhou) Co., Ltd.?

The most recent FDA inspection on file ended Nov 8, 2024 at Guangzhou, China and was classified OAI. FDA has 1 inspection of Aopline Health Industry Technology (Guangzhou) Co., Ltd. on file, 1 of them classified OAI (official action indicated).

Need more than this page shows? Ask about Aopline Health Industry Technology (Guangzhou) Co., Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.